Global Insomnia Therapeutics Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 112995
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Insomnia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Insomnia Therapeutics Drugs market size is estimated to be worth US$ 3006.2 million in 2021 and is forecast to a readjusted size of USD 3764 million by 2028 with a CAGR of 3.3% during review period. Prescription accounting for % of the Insomnia Therapeutics Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Benzodiazepines segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Insomnia Therapeutics Drugs include Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Benzodiazepines

Nonbenzodiazepines

Antidepressants

Orexin Antagonists

Melatonin Antagonists

Others

Market segment by Application, can be divided into

Prescription

Over-the-Counter (OTC)

Market segment by players, this report covers

Takeda Pharmaceutical Company Ltd.

Vanda Pharmaceuticals

Merck & Co., Inc.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Mylan N.V.

Sumitomo Dainippon Pharma Co., Ltd

Sanofi

Paratek Pharmaceuticals Inc.

Ebb Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Insomnia Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Insomnia Therapeutics Drugs, with revenue, gross margin and global market share of Insomnia Therapeutics Drugs from 2019 to 2022.

Chapter 3, the Insomnia Therapeutics Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Insomnia Therapeutics Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Insomnia Therapeutics Drugs research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Insomnia Therapeutics Drugs

1.2 Classification of Insomnia Therapeutics Drugs by Type

1.2.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2021

1.2.3 Benzodiazepines

1.2.4 Nonbenzodiazepines

1.2.5 Antidepressants

1.2.6 Orexin Antagonists

1.2.7 Melatonin Antagonists

1.2.8 Others

1.3 Global Insomnia Therapeutics Drugs Market by Application

1.3.1 Overview: Global Insomnia Therapeutics Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Prescription

1.3.3 Over-the-Counter (OTC)

1.4 Global Insomnia Therapeutics Drugs Market Size & Forecast

1.5 Global Insomnia Therapeutics Drugs Market Size and Forecast by Region

1.5.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Insomnia Therapeutics Drugs Market Size by Region, (2017-2022)

1.5.3 North America Insomnia Therapeutics Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Insomnia Therapeutics Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Insomnia Therapeutics Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Insomnia Therapeutics Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Insomnia Therapeutics Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Insomnia Therapeutics Drugs Market Drivers

1.6.2 Insomnia Therapeutics Drugs Market Restraints

1.6.3 Insomnia Therapeutics Drugs Trends Analysis

2 Company Profiles

2.1 Takeda Pharmaceutical Company Ltd.

2.1.1 Takeda Pharmaceutical Company Ltd. Details

2.1.2 Takeda Pharmaceutical Company Ltd. Major Business

2.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions

2.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans

2.2 Vanda Pharmaceuticals

2.2.1 Vanda Pharmaceuticals Details

2.2.2 Vanda Pharmaceuticals Major Business

2.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions

2.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Vanda Pharmaceuticals Recent Developments and Future Plans

2.3 Merck & Co., Inc.

2.3.1 Merck & Co., Inc. Details

2.3.2 Merck & Co., Inc. Major Business

2.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions

2.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Merck & Co., Inc. Recent Developments and Future Plans

2.4 Pfizer Inc.

2.4.1 Pfizer Inc. Details

2.4.2 Pfizer Inc. Major Business

2.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions

2.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Pfizer Inc. Recent Developments and Future Plans

2.5 Teva Pharmaceutical Industries Ltd.

2.5.1 Teva Pharmaceutical Industries Ltd. Details

2.5.2 Teva Pharmaceutical Industries Ltd. Major Business

2.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions

2.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

2.6 Mylan N.V.

2.6.1 Mylan N.V. Details

2.6.2 Mylan N.V. Major Business

2.6.3 Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions

2.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Mylan N.V. Recent Developments and Future Plans

2.7 Sumitomo Dainippon Pharma Co., Ltd

2.7.1 Sumitomo Dainippon Pharma Co., Ltd Details

2.7.2 Sumitomo Dainippon Pharma Co., Ltd Major Business

2.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions

2.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Insomnia Therapeutics Drugs Product and Solutions

2.8.4 Sanofi Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sanofi Recent Developments and Future Plans

2.9 Paratek Pharmaceuticals Inc.

2.9.1 Paratek Pharmaceuticals Inc. Details

2.9.2 Paratek Pharmaceuticals Inc. Major Business

2.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions

2.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Paratek Pharmaceuticals Inc. Recent Developments and Future Plans

2.10 Ebb Therapeutics

2.10.1 Ebb Therapeutics Details

2.10.2 Ebb Therapeutics Major Business

2.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions

2.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Ebb Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Insomnia Therapeutics Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Insomnia Therapeutics Drugs Players Market Share in 2021

3.2.2 Top 10 Insomnia Therapeutics Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Insomnia Therapeutics Drugs Players Head Office, Products and Services Provided

3.4 Insomnia Therapeutics Drugs Mergers & Acquisitions

3.5 Insomnia Therapeutics Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Insomnia Therapeutics Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Insomnia Therapeutics Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Insomnia Therapeutics Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Insomnia Therapeutics Drugs Revenue by Type (2017-2028)

6.2 North America Insomnia Therapeutics Drugs Revenue by Application (2017-2028)

6.3 North America Insomnia Therapeutics Drugs Market Size by Country

6.3.1 North America Insomnia Therapeutics Drugs Revenue by Country (2017-2028)

6.3.2 United States Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Insomnia Therapeutics Drugs Revenue by Type (2017-2028)

7.2 Europe Insomnia Therapeutics Drugs Revenue by Application (2017-2028)

7.3 Europe Insomnia Therapeutics Drugs Market Size by Country

7.3.1 Europe Insomnia Therapeutics Drugs Revenue by Country (2017-2028)

7.3.2 Germany Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

7.3.3 France Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region

8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2017-2028)

8.3.2 China Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8.3.5 India Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Insomnia Therapeutics Drugs Revenue by Type (2017-2028)

9.2 South America Insomnia Therapeutics Drugs Revenue by Application (2017-2028)

9.3 South America Insomnia Therapeutics Drugs Market Size by Country

9.3.1 South America Insomnia Therapeutics Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country

10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Insomnia Therapeutics Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Insomnia Therapeutics Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Insomnia Therapeutics Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Insomnia Therapeutics Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Insomnia Therapeutics Drugs Revenue Market Share by Region (2023-2028)

Table 6. Takeda Pharmaceutical Company Ltd. Corporate Information, Head Office, and Major Competitors

Table 7. Takeda Pharmaceutical Company Ltd. Major Business

Table 8. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product and Solutions

Table 9. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Vanda Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Vanda Pharmaceuticals Major Business

Table 12. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product and Solutions

Table 13. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Merck & Co., Inc. Major Business

Table 16. Merck & Co., Inc. Insomnia Therapeutics Drugs Product and Solutions

Table 17. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Pfizer Inc. Major Business

Table 20. Pfizer Inc. Insomnia Therapeutics Drugs Product and Solutions

Table 21. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. Teva Pharmaceutical Industries Ltd. Major Business

Table 24. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product and Solutions

Table 25. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Mylan N.V. Corporate Information, Head Office, and Major Competitors

Table 27. Mylan N.V. Major Business

Table 28. Mylan N.V. Insomnia Therapeutics Drugs Product and Solutions

Table 29. Mylan N.V. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Sumitomo Dainippon Pharma Co., Ltd Corporate Information, Head Office, and Major Competitors

Table 31. Sumitomo Dainippon Pharma Co., Ltd Major Business

Table 32. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product and Solutions

Table 33. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sanofi Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi Major Business

Table 36. Sanofi Insomnia Therapeutics Drugs Product and Solutions

Table 37. Sanofi Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Paratek Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Paratek Pharmaceuticals Inc. Major Business

Table 40. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product and Solutions

Table 41. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Ebb Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. Ebb Therapeutics Major Business

Table 44. Ebb Therapeutics Insomnia Therapeutics Drugs Product and Solutions

Table 45. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Insomnia Therapeutics Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Insomnia Therapeutics Drugs Players Head Office, Products and Services Provided

Table 50. Insomnia Therapeutics Drugs Mergers & Acquisitions in the Past Five Years

Table 51. Insomnia Therapeutics Drugs New Entrants and Expansion Plans

Table 52. Global Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2017-2022)

Table 53. Global Insomnia Therapeutics Drugs Revenue Share by Type (2017-2022)

Table 54. Global Insomnia Therapeutics Drugs Revenue Forecast by Type (2023-2028)

Table 55. Global Insomnia Therapeutics Drugs Revenue by Application (2017-2022)

Table 56. Global Insomnia Therapeutics Drugs Revenue Forecast by Application (2023-2028)

Table 57. North America Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Insomnia Therapeutics Drugs Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Insomnia Therapeutics Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Insomnia Therapeutics Drugs Picture

Figure 2. Global Insomnia Therapeutics Drugs Revenue Market Share by Type in 2021

Figure 3. Benzodiazepines

Figure 4. Nonbenzodiazepines

Figure 5. Antidepressants

Figure 6. Orexin Antagonists

Figure 7. Melatonin Antagonists

Figure 8. Others

Figure 9. Insomnia Therapeutics Drugs Revenue Market Share by Application in 2021

Figure 10. Prescription Picture

Figure 11. Over-the-Counter (OTC) Picture

Figure 12. Global Insomnia Therapeutics Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Insomnia Therapeutics Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Insomnia Therapeutics Drugs Revenue Market Share by Region (2017-2028)

Figure 15. Global Insomnia Therapeutics Drugs Revenue Market Share by Region in 2021

Figure 16. North America Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Insomnia Therapeutics Drugs Market Drivers

Figure 22. Insomnia Therapeutics Drugs Market Restraints

Figure 23. Insomnia Therapeutics Drugs Market Trends

Figure 24. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans

Figure 25. Vanda Pharmaceuticals Recent Developments and Future Plans

Figure 26. Merck & Co., Inc. Recent Developments and Future Plans

Figure 27. Pfizer Inc. Recent Developments and Future Plans

Figure 28. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

Figure 29. Mylan N.V. Recent Developments and Future Plans

Figure 30. Sumitomo Dainippon Pharma Co., Ltd Recent Developments and Future Plans

Figure 31. Sanofi Recent Developments and Future Plans

Figure 32. Paratek Pharmaceuticals Inc. Recent Developments and Future Plans

Figure 33. Ebb Therapeutics Recent Developments and Future Plans

Figure 34. Global Insomnia Therapeutics Drugs Revenue Share by Players in 2021

Figure 35. Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Insomnia Therapeutics Drugs Revenue Market Share in 2021

Figure 37. Global Top 10 Players Insomnia Therapeutics Drugs Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Insomnia Therapeutics Drugs Revenue Share by Type in 2021

Figure 40. Global Insomnia Therapeutics Drugs Market Share Forecast by Type (2023-2028)

Figure 41. Global Insomnia Therapeutics Drugs Revenue Share by Application in 2021

Figure 42. Global Insomnia Therapeutics Drugs Market Share Forecast by Application (2023-2028)

Figure 43. North America Insomnia Therapeutics Drugs Sales Market Share by Type (2017-2028)

Figure 44. North America Insomnia Therapeutics Drugs Sales Market Share by Application (2017-2028)

Figure 45. North America Insomnia Therapeutics Drugs Revenue Market Share by Country (2017-2028)

Figure 46. United States Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Insomnia Therapeutics Drugs Sales Market Share by Type (2017-2028)

Figure 50. Europe Insomnia Therapeutics Drugs Sales Market Share by Application (2017-2028)

Figure 51. Europe Insomnia Therapeutics Drugs Revenue Market Share by Country (2017-2028)

Figure 52. Germany Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Insomnia Therapeutics Drugs Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Insomnia Therapeutics Drugs Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Insomnia Therapeutics Drugs Revenue Market Share by Region (2017-2028)

Figure 60. China Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Insomnia Therapeutics Drugs Sales Market Share by Type (2017-2028)

Figure 67. South America Insomnia Therapeutics Drugs Sales Market Share by Application (2017-2028)

Figure 68. South America Insomnia Therapeutics Drugs Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Insomnia Therapeutics Drugs Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Insomnia Therapeutics Drugs Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Insomnia Therapeutics Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source